Armistice Capital’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,364,000
| Closed | -$5.89M | – | 254 |
|
|
2024
Q3 | $5.89M | Buy |
2,364,000
+28,000
| +1% | +$69.7K | 0.09% | 109 |
|
|
2024
Q2 | $6.17M | Buy |
2,336,000
+39,000
| +2% | +$103K | 0.08% | 103 |
|
|
2024
Q1 | $4.73M | Buy |
2,297,000
+108,000
| +5% | +$222K | 0.06% | 122 |
|
|
2023
Q4 | $3.94M | Buy |
2,189,000
+365,000
| +20% | +$657K | 0.05% | 127 |
|
|
2023
Q3 | $2.5M | Sell |
1,824,000
-18,803
| -1% | -$25.8K | 0.04% | 127 |
|
|
2023
Q2 | $2.52M | Buy |
+1,842,803
| New | +$2.52M | 0.04% | 134 |
|